These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6371015)

  • 1. Developing new drugs for ovarian cancer: a challenging task in a changing reality.
    Canetta RM; Carter SK
    J Cancer Res Clin Oncol; 1984; 107(2):111-24. PubMed ID: 6371015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental model systems of ovarian cancer: applications to the design and evaluation of new treatment approaches.
    Hamilton TC; Young RC; Ozols RF
    Semin Oncol; 1984 Sep; 11(3):285-98. PubMed ID: 6385258
    [No Abstract]   [Full Text] [Related]  

  • 3. [Secondary chemotherapy in advanced ovarian cancer--new drugs].
    Bruntsch U
    Onkologie; 1985 Dec; 8(6):410-6. PubMed ID: 3912697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [In vitro evaluation of anticancer drugs and retrospective clinical trials with the human tumor cloning system].
    Inoue K; Ogawa M; Mukaiyama T; Mitsui I; Inagaki J; Horikoshi N
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):59-65. PubMed ID: 3889195
    [No Abstract]   [Full Text] [Related]  

  • 5. [Chemotherapy of ovarian cancer based on in vitro (HTCA) and in vivo (nude mice) chemosensitivity testing].
    Sagawa T; Yamashita K; Kawamura M; Shimizu T; Haga H; Yorozu Y; Kasamo M; Fujita M
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jul; 37(7):1197-204. PubMed ID: 2411831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigational therapies for epithelial ovarian cancer.
    Kavanagh JJ
    Clin Obstet Gynecol; 1985 Dec; 28(4):846-52. PubMed ID: 4075634
    [No Abstract]   [Full Text] [Related]  

  • 7. New agents in ovarian cancer.
    Slayton RE
    Int J Radiat Oncol Biol Phys; 1982 Aug; 8(8):1431-4. PubMed ID: 7141920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of nude mouse xenografts as preclinical drug screens. Further studies on in vitro growth of xenograft tumor colony-forming cells.
    Taetle R; Honeysett JM; Rosen F; Shoemaker R
    Cancer; 1986 Nov; 58(9):1969-78. PubMed ID: 3756816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of nude mouse xenografts as preclinical drug screens: in vivo activity of established chemotherapeutic agents against melanoma and ovarian carcinoma xenografts.
    Taetle R; Rosen F; Abramson I; Venditti J; Howell S
    Cancer Treat Rep; 1987 Mar; 71(3):297-304. PubMed ID: 3815395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Initial treatment for ovarian cancer].
    Suzuki M; Fujiwara H; Takei Y
    Gan To Kagaku Ryoho; 2009 Feb; 36(2):224-9. PubMed ID: 19263611
    [No Abstract]   [Full Text] [Related]  

  • 11. Update on in vitro testing on new drugs in ovarian cancer and melanoma.
    Salmon SE; Meyskens FL; Alberts DS; Soehnlen B; Young L
    Cancer Treat Rep; 1981; 65(5-6):532-3. PubMed ID: 7195308
    [No Abstract]   [Full Text] [Related]  

  • 12. Carboplatin in the treatment of ovarian cancer.
    Alberts DS; Mason-Liddil N
    Semin Oncol; 1989 Apr; 16(2 Suppl 5):19-26. PubMed ID: 2655095
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human tumor cloning assay in cancer drug development. A review.
    Agre P; Williams TE
    Invest New Drugs; 1983; 1(1):33-45. PubMed ID: 6381376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent results of in vitro drug prediction in human tumour chemotherapy.
    Nissen E; Tanneberger S; Projan A; Morack G; Peek U
    Arch Geschwulstforsch; 1978; 48(7):667-72. PubMed ID: 736748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A systematic overview of chemotherapy effects in ovarian cancer.
    Högberg T; Glimelius B; Nygren P;
    Acta Oncol; 2001; 40(2-3):340-60. PubMed ID: 11441940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Drug sensitivity testing of gynecologic tumors using Volm's test and stem cell assay].
    Eidtmann H; Jonat W; Maass H
    Geburtshilfe Frauenheilkd; 1985 Jul; 45(7):477-81. PubMed ID: 4029587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of in vitro drug screening leads using experimental models of human ovarian cancer.
    Louie KG; Hamilton TC; Shoemaker RH; Young RC; Ozols RF
    Invest New Drugs; 1992 Jul; 10(2):73-8. PubMed ID: 1500268
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current and future directions of clinical trials for ovarian cancer.
    Gardner GJ; Jewell EL
    Cancer Control; 2011 Jan; 18(1):44-51. PubMed ID: 21273979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrent and 2nd line therapy in ovarian carcinoma: an overview of conventional systemic therapy modalities].
    du Bois A; Lück HJ; Meerpohl HG
    Zentralbl Gynakol; 1997; 119(7):299-323. PubMed ID: 9340970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systematic review of first-line chemotherapy for newly diagnosed postoperative patients with stage II, III, or IV epithelial ovarian cancer.
    Covens A; Carey M; Bryson P; Verma S; Fung Kee Fung M; Johnston M
    Gynecol Oncol; 2002 Apr; 85(1):71-80. PubMed ID: 11925123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.